Ernexa Therapeutics joins Virtual Investor Closing Bell Series webcast

Ernexa Therapeutics will join the Virtual Investor Closing Bell Series on Oct. 15, 2026 at 4:00 p.m. ET. Management plans a corporate update, outlining strategy for its cell-therapy platform and progress of lead program ERNA-101 toward clinical development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via (Ref. ID: 202610121605PRIMZONEFULLFEED9844111) on October 12, 2026, and is solely responsible for the information contained therein. (C)